期刊文献+

多不饱和脂肪酸n-6/n-3对子宫内膜癌小鼠皮下种植瘤中AKT、roTOR表达的影响

Effects of different ratios of n -6/n -3 polyunsaturated fatty acids on the expressions of AKT and mTOR in mice with endometrial carcinoma
下载PDF
导出
摘要 目的研究不同比例n-6/n-3多不饱和脂肪酸(PUFAs)对人子宫内膜癌瘤组织中AKT、mTOR表达的影响。方法建立人子宫内膜癌小鼠皮下种植瘤模型,40只实验BALB/C模型小鼠随机分为A组(n-6PU—FAs)、B组(10:1n-6/n-3PUFAs)、C组(对照)、D组(1:1n-6/n-3PUFAs)、E组(n-3PUFAs),每组8只。A、B、D、E组分别灌胃给予不同比例PUFAs,C组给予等量生理盐水。6周后处死小鼠,切取皮下种植瘤组织,苏木精-伊红染色镜下定位观察肿瘤组织形态,免疫组化SP法检测种植瘤组织中AKT、mTOR蛋白表达,RT—PCR法检测各组种植瘤组织中AKT、mTOR的mRNA表达。结果苏木精-伊红染色结果确认皮下种植瘤模型建立成功;免疫组化SP法和RT—PCR结果显示n-6PUFAs和10:1n-6/n-3PuFAs组中AKT、mTOR的蛋白和mRNA的表达增加,与对照组相比差异有统计学意义(P〈0.05);n-3PUFAs和1:1n-6/n-3PUFAs组中的中AKT、mTOR的蛋白和mRNA表达下降,与对照组相比差异有统计学意义(P〈0.05)。结论不同比例的n-6/n-3PUFAs对人子宫内膜癌的作用机制可能是通过P13ICAKT/mTOR信号通路调节AKT、mTOR的表达而起作用的。 Objective To investigate the effects of different ratios of n - 6/n - 3 polyunsaturated fatty acids on the expressions of AKT and mTOR in mice with endometrial carcinoma. Methods A tumor model of mice was established where the mice were subcutaneously injected with human endometrial carcinoma. The mice ( n = 40) were randomly di- vided into five groups according to their different treatments : group A ( n - 6 PUFAs) , group B ( 10:1 n - 6/n - 3 PU- FAs) , group C (control group), group D (1:1 n-6/n-3 PUFAs) and group E (n-3 PUFAs) , eight mice in each group. The mice in experimental groups were intragastrically administrated with different proportional PUFAs, while the mice in control group were fed with an equal amount of normal saline. Six weeks later, these mice were sacrificed and the subcutaneous tumor tissues were excised. The histomorphological changes of the tissues were detected by hematoxylin - eosin staining. The expressions of AKT and roTOR were examined by SP - IHC method, while the amounts of AKT and mTOR mRNA were accessed by RT - PCR. Results The establishment of the model of mice with human endometrial carcinoma was confirmed by HE staining. Then enhanced expressions of AKT and roTOR at protein and mRNA levels were found in the n -6 PUFAs group and the 10:1 n -6/n -3 PUFAs group, when compared with the control group (P 〈 0.05 ). However, the n -3 PUFAs group and the 1:1 n -6/n -3 PUFAs group presented reduced protein and mRNA expressions of AKT and roTOR than the control group ( P 〈 0.05 ). Conclusion The effects of different ratios of n - 6/ n -3 PUFAs on endometrial carcinoma may be attributed to various abilities of the PUFAs to regulate the expressions of AKT and mTOR through the PI3k/AKT/mTOR signal pathway.
作者 丁璇 陆晓媛
出处 《徐州医学院学报》 CAS 2014年第4期264-267,共4页 Acta Academiae Medicinae Xuzhou
基金 徐州医学院研究生科技创新计划(XYLC-1223)
关键词 多不饱和脂肪酸 子宫内膜癌 皮下种植瘤 AKT MTOR polyunsaturated fatty acids endometrial carcinoma subcutaneously transplantable tumor AKT mTOR
  • 相关文献

参考文献12

  • 1Boruban MC, Altundag K, Kilic GS, et al. From endometrial hy- perplasia to endometrial cancer: insight into the biology and possi- ble medical preventive measures[ J]. Eur J Cancer Prev, 2008, 17 (2) :133 -138.
  • 2Gerber M. Omega -3 fatty acids and cancers: a systematic update review of epidemiological studies [ J ]. Br J Nutr, 2012, 107 ( Sup- pl 2) : S228 - S239.
  • 3Gerber M. Background review paper on total fat, fatty acid intake and cancers [ J]. Ann Nutr Metab, 2009, 55 ( 1 - 3 ) : 140 - 161.
  • 4范秀华,邢小芬,李晓,乔书花,胡建秀.子宫内膜癌动物模型的构建[J].河北医药,2010,32(24):3436-3437. 被引量:2
  • 5Yoshida Y, Kurokawa T, Horiuchi Y, et al. Localisation of phos- phorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer [ J]. Eur J Caner, 2010, 46 ( 18 ) : 3445 - 3452.
  • 6王静,糜漫天,韦娜,王斌.n-6/n-3多不饱和脂肪酸对乳腺癌大鼠乳腺癌组织CYP17和CYP19表达的影响[J].第三军医大学学报,2007,29(8):674-677. 被引量:4
  • 7Khan AA, Alam M, Tufail S, et al. Synthesis and characterization of novel PUFA esters exhibiting potential anticancer activities: an in vitro study [ J]. Eur J Med Chem, 2011, 46 (10) : 4878 - 4886.
  • 8Cataldi A, Zauli G, Di Pietro R,et al. Involvement of the pathway phosphatidylinositol- 3 -kinase/AKT- 1 in the establishment of the survival response to ionizing radiation [ J]. Cell Signal, 2001, 13(5) : 369 -375.
  • 9黄嘉佳,林桐榆.mTOR通路及其抑制剂抗肿瘤的研究进展[J].癌症,2007,26(12):1397-1403. 被引量:21
  • 10Choi CH, Lee JS, Kim SR, et al. Clinical significance of pmTOR expression in endometrioid endometrial carcinoma [ J]. Eur J Ob- stet Gynecol Reprod Biol, 2010, 153(2) : 207 -210.

二级参考文献15

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部